Haleos Labs Limited
₹1286.50
(-0.09%)
Tue, 07 Apr 2026, 10:42 am
Health Technology
Biotechnology
24.5KHaleos Labs Limited Debt to Equity Ratio
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 17.57 | 9.35 | 5.20 | 11.04 | 8.30 | 13.71 | 22.57 | 16.24 |
| Price to book ratio | 0 | 1.29 | 1.57 | 0.46 | 1.16 | 1.38 | 0.93 | 1.16 | 1.66 |
| Price to sales ratio | 0 | 0.55 | 0.45 | 0.21 | 0.57 | 0.60 | 0.50 | 0.67 | 0.95 |
| Price to cash flow ratio | 0 | 18.85 | 6 | 4.60 | 4.53 | 0 | 13.83 | 11.34 | 10.96 |
| Enterprise value | 0 | 1.41B | 2.11B | 1.1B | 2.03B | 2.98B | 2.73B | 3.21B | 4.27B |
| Enterprise value to EBITDA ratio | 0 | 15.48 | 6.96 | 5.15 | 6.24 | 9.16 | 9.70 | 10.45 | 9.53 |
| Debt to equity ratio | 0.32 | 0.31 | 0.44 | 0.56 | 0.50 | 0.52 | 0.60 | 0.57 | 0.44 |
| Return on equity % | 0 | 7.68 | 18.33 | 9.17 | 11.07 | 17.99 | 7.15 | 5.26 | 10.77 |
Haleos Labs Limited Debt to Equity Ratio
The Haleos Labs Limited Debt to Equity Ratio is a key financial metric used by investors to evaluate Haleos Labs Limited's valuation, profitability, and overall financial performance. Tracking the Haleos Labs Limited Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Haleos Labs Limited (NSE: HALEOSLABS, BSE: 540679) is currently trading at ₹1286.50, with a market capitalization of ₹3.93B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Haleos Labs Limited Debt to Equity Ratio is essential for fundamental analysis.
Haleos Labs Limited Debt to Equity Ratio Current Value
The current Haleos Labs Limited Debt to Equity Ratio stands at 0.44.
The Haleos Labs Limited Debt to Equity Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Haleos Labs Limited Debt to Equity Ratio Historical Trend
The Haleos Labs Limited Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.44
- 2023: 0.57
- 2022: 0.60
- 2021: 0.52
- 2020: 0.50
The decline in Haleos Labs Limited Debt to Equity Ratio indicates improving financial efficiency or better earnings growth.
What Haleos Labs Limited Debt to Equity Ratio Indicates for Investors
The Haleos Labs Limited Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Haleos Labs Limited Debt to Equity Ratio Analysis Summary
The Haleos Labs Limited Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Haleos Labs Limited Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Haleos Labs Limited Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800